Navigation Links
Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
Date:2/20/2008

of the prior year. For the nine-month period ended January 25, 2008, we reported a net loss of $13.2 million, or $0.50 per share, compared to a loss of $40.4 million, or $1.59 per share, in the nine-month period ended January 26, 2007.

Balance sheet

The Company's cash balances have increased by $5.1 million since the end of the prior fiscal year. This increase reflects an improvement in operating results, including positive operating cash flow in the most recent quarter and receipt of the licensing fee referred to earlier, offset by the repayment of all amounts owed under the revolving line of credit.

Share repurchase program

The company's Board of Directors ("Board") has authorized the repurchase of up to one million shares of the company's outstanding common stock. The company anticipates the share repurchase program will be implemented using open-market purchases. The number of shares actually repurchased and the timing of any repurchases will depend on factors such as the stock price, economic and market conditions, and corporate and regulatory requirements. The share repurchase program may be suspended or discontinued at any time. The repurchase program announced today supersedes the repurchase program announced in May 2006.

Progress towards objectives

As announced previously, the company's objectives are to:

-- Return to positive cash flow and profitability as soon as possible;

-- Build sustainable growth in the company's core epilepsy business;

-- Refine the company's clinical and payor strategies for depression;

-- Continue to seek partnership opportunities; and

-- Improve communication with all stakeholders.

"During our fiscal third quarter, we again made good progress in several areas. With respect to our first objective, we achieved a small operating profit, the first in more than three years, and positive operating cash flow. While we are encouraged by this result, which
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Cyberonics Licenses Obesity-Related Patents
2. Cyberonics Announces Conference Call to Discuss FY08 Q3 Financial Results
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 30, 2015 Wright & Schulte LLC, ... notes that the number of Syngenta corn lawsuits ... in U.S. District Court, District of Kansas, have risen ... "According to an update released by the U.S. Judicial ... least 493 Syngenta lawsuits are now consolidated in the ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 A new ... in California Superior Court on behalf of a child ... defect after his mother was prescribed the anti-nausea medication ... March 6th filing in Alameda Superior Court, the baby’s ... vomiting that she experienced in the early months of ...
(Date:3/30/2015)... 30, 2015 On March 11, 2015, Elle ... Away Fat,” details six new treatment options for dealing with ... one is a topical product. The other three technologies use ... Liposonix ) or freezing cold ( CoolSculpting ) to kill ... now available to us to permanently remove unwanted fat," says ...
(Date:3/30/2015)... In a recent report published by ... Christie is championing effective drug and alcohol treatment for ... to recover funds to stabilize the addiction treatment programs, ... of drug and alcohol addiction. Harbor Village Detox is ... substance use disorders in New Jersey, in hopes to ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 This ... software market over the forecast period of 2014 ... at a CAGR of 6.5% from 2014 to ... , In this report, the global pharmacovigilance and ... many segments on the basis of functionality, namely, ...
Breaking Medicine News(10 mins):Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 4
... and cursed: the Stanev gypsy family parted with their three ... European Union, rescued this week from years of abuse . ... our bears, our kids?" a tearful Velichka Staneva, 58, cried ... son, Veselin, led out his 19-year-old male bear Misho and ...
... Tens of thousands Saturday staged the Gay Pride parade ... to grant homosexual couples legal status and override Vatican ... which included transvestites and lawmakers, marched under a baking ... of Saint John Lateran, the official ecclesiastical seat of ...
... been together for 18 years, and rocker Jon Bon Jovi insists ... another woman. ,Jovi, who has seen the collapse ... Richie Sambora, insists that his wife is really something special to ... that he's 'had his lapses'. ,"I wouldn't trade her in ...
... Jessica Alba prefers a hot one-night stand to being in ... magazine, admitted that she doesn't think that one-night stands or ... that she has indulged in several one-night trysts. ,"I ... with different people. I don't think a girl's a sl*t ...
... England's top footballers woke up as married men Sunday ... ultimate WAG wedding weekend. ,The off-field antics ... of England's footballers were as much the focus as ... World Cup. And there was an almighty fixture pile-up ...
... expensive technique for mutating those large, non-gene stretches of DNA. ... human genetic blueprint , yet diseases can result not only ... controls genes. ,Diseases are known to occur as ... method allows us to evaluate what these sequences do, says ...
Cached Medicine News:Health News:Europe's Last Dancing Bears Sheltered After Years of Abuse 2Health News:Gay Pride Attracts Tens of Thousands in Rome 2Health News:WAG Wedding Extravaganza for England Footballers 2Health News:Genome Annotation by Mutation 2Health News:Genome Annotation by Mutation 3Health News:Genome Annotation by Mutation 4Health News:Genome Annotation by Mutation 5
(Date:3/30/2015)... ATLANTA , March 30, 2015  Edelberg ... the first of its kind, real-time medical coding ... the patient, physician, scribe and medical coder at ... lengthy collaboration initiative with ScribeAmerica, EA has successfully ... method for real-time interaction between scribe and medical ...
(Date:3/30/2015)... Calif. , March 30, 2015 ... that it has initiated a multi-dose Phase 1 ... the lead molecule in DURECT,s Epigenomic Regulator Program.  ... (NCE) that may have broad applicability in metabolic ... and nonalcoholic steatohepatitis (NASH).  It may also play ...
(Date:3/30/2015)... March 30, 2015   GlassesUSA , the online retailer ... $12.5 million in new financing led by Viola Private ... will further GlassesUSA,s aggressive business growth and accelerate their expansion ... online eyewear, both B2C and B2B. GlassesUSA was ... Eldad Rothman , and CTO Roy Yamner . ...
Breaking Medicine Technology:Edelberg & Associates and ScribeAmerica Partner to Launch Healthcare Industry's First Ever Real-time Medical Coding Solution 2Edelberg & Associates and ScribeAmerica Partner to Launch Healthcare Industry's First Ever Real-time Medical Coding Solution 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3
... 16, 2010 New results from an observational ... American Heart Association (AHA) Scientific Sessions annual meeting ... to coronary artery bypass graft surgery (CABG) had ... treated with Plavix® (clopidogrel) (2.3 percent versus 8.7 ...
... Decision Resources, one of the world,s leading research ... that, owing to the launch of several novel agents, ... than triple from approximately $2 billion in 2009 to ... France, Germany, Italy, Spain, the United Kingdom and Japan. ...
Cached Medicine Technology:Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 2Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 3Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 4Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 5Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 6The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments 2The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments 3
Girard angled tying forceps made of titanium has angled 45 shafts with 4 mm tying platforms, width of shafts 0,25 mm, TCI platforms, round handle, diam. 6 mm, overall length 102 mm....
McPherson curved tying forceps made of titanium has curved shafts with 8 mm tying platforms, width of shafts 0,25 mm, TCI platforms, flat handle, width 6 mm, overall length 85 mm....
Tying forceps with flat serrated handle 88 mm, made of titanium, angled 30 with 4.5 mm tying platform....
Round handle colibri tying forceps with 5 mm titanium coated platforms. Length 100 mm....
Medicine Products: